NO301479B1 - Trisubstituerte pyrimido £5,4-d| pyrimidiner for modulering av multimedikamentresistens, legemidler som inneholder disse forbindelser og fremgangsmåter ved fremstilling av dem - Google Patents

Trisubstituerte pyrimido £5,4-d| pyrimidiner for modulering av multimedikamentresistens, legemidler som inneholder disse forbindelser og fremgangsmåter ved fremstilling av dem

Info

Publication number
NO301479B1
NO301479B1 NO942853A NO942853A NO301479B1 NO 301479 B1 NO301479 B1 NO 301479B1 NO 942853 A NO942853 A NO 942853A NO 942853 A NO942853 A NO 942853A NO 301479 B1 NO301479 B1 NO 301479B1
Authority
NO
Norway
Prior art keywords
pyrimidines
preparing
compounds
methods
multidrug resistance
Prior art date
Application number
NO942853A
Other languages
English (en)
Norwegian (no)
Other versions
NO942853L (no
NO942853D0 (fr
Inventor
Armin Heckel
Uwe Bamberger
Annerose Mauz
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO942853D0 publication Critical patent/NO942853D0/no
Publication of NO942853L publication Critical patent/NO942853L/no
Publication of NO301479B1 publication Critical patent/NO301479B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO942853A 1993-08-02 1994-08-01 Trisubstituerte pyrimido £5,4-d| pyrimidiner for modulering av multimedikamentresistens, legemidler som inneholder disse forbindelser og fremgangsmåter ved fremstilling av dem NO301479B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4325900A DE4325900A1 (de) 1993-08-02 1993-08-02 Trisubstituierte Pyrimido [5,4-d] pyrimidine zur Modulation der Multidrugresistenz, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Publications (3)

Publication Number Publication Date
NO942853D0 NO942853D0 (fr) 1994-08-01
NO942853L NO942853L (no) 1995-02-03
NO301479B1 true NO301479B1 (no) 1997-11-03

Family

ID=6494272

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942853A NO301479B1 (no) 1993-08-02 1994-08-01 Trisubstituerte pyrimido £5,4-d| pyrimidiner for modulering av multimedikamentresistens, legemidler som inneholder disse forbindelser og fremgangsmåter ved fremstilling av dem

Country Status (22)

Country Link
US (1) US5618814A (fr)
EP (1) EP0645390A1 (fr)
JP (1) JPH0789963A (fr)
KR (1) KR950005828A (fr)
CN (1) CN1041091C (fr)
AU (1) AU683888B2 (fr)
BG (1) BG98931A (fr)
CA (1) CA2129179A1 (fr)
CZ (1) CZ184594A3 (fr)
DE (1) DE4325900A1 (fr)
EE (1) EE9400255A (fr)
FI (1) FI943574A (fr)
HU (1) HUT70957A (fr)
IL (1) IL110509A (fr)
NO (1) NO301479B1 (fr)
NZ (1) NZ264133A (fr)
PL (1) PL304512A1 (fr)
RO (1) RO113557B1 (fr)
RU (1) RU94028278A (fr)
SK (1) SK91594A3 (fr)
TW (1) TW251286B (fr)
ZA (1) ZA945689B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW414798B (en) * 1994-09-07 2000-12-11 Thomae Gmbh Dr K Pyrimido (5,4-d) pyrimidines, medicaments comprising these compounds, their use and processes for their preparation
DE19608653A1 (de) * 1996-03-06 1997-09-11 Thomae Gmbh Dr K Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
USRE37234E1 (en) * 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
US7618975B2 (en) * 2003-07-03 2009-11-17 Myriad Pharmaceuticals, Inc. 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
DE102004002557A1 (de) * 2004-01-17 2005-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2592900A1 (fr) 2005-01-03 2006-07-13 Myriad Genetics Inc. Composes et utilisation therapeutique associee
CN115650827B (zh) * 2022-10-27 2024-03-15 戊言医药科技（上海）有限公司 用于一类蒽环类毒素衍生物的制备方法、中间体化合物及合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3069211D1 (en) * 1979-07-03 1984-10-25 Thomae Gmbh Dr K 2-(perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them
DE2931573A1 (de) * 1979-08-03 1981-02-26 Thomae Gmbh Dr K Mittel zur bekaempfung des wachstums von krebszellen und dessen herstellung
DE3049207A1 (de) * 1980-12-27 1982-07-29 Dr. Karl Thomae Gmbh, 7950 Biberach Neue trisubstituierte pyrimido (5,4-d) pyrimidine, ihre herstellung und ihre verwendung als arzneimittel
DE3423092A1 (de) * 1984-06-22 1986-01-02 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 8-alkylthio-2-piperazino-pyrimido(5,4-d) pyrimidine, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE3833392A1 (de) * 1988-10-01 1990-04-05 Thomae Gmbh Dr K Verwendung von pyrimido(5,4-d)pyrimidinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
HU9402253D0 (en) 1994-09-28
CN1106405A (zh) 1995-08-09
AU683888B2 (en) 1997-11-27
JPH0789963A (ja) 1995-04-04
PL304512A1 (en) 1995-02-06
KR950005828A (ko) 1995-03-20
BG98931A (en) 1995-09-29
ZA945689B (en) 1996-02-01
IL110509A (en) 1998-01-04
IL110509A0 (en) 1994-10-21
CA2129179A1 (fr) 1995-02-03
FI943574A (fi) 1995-02-03
NZ264133A (en) 1996-05-28
FI943574A0 (fi) 1994-08-01
SK91594A3 (en) 1995-04-12
EE9400255A (et) 1996-02-15
EP0645390A1 (fr) 1995-03-29
AU6881394A (en) 1995-02-09
DE4325900A1 (de) 1995-02-09
TW251286B (fr) 1995-07-11
NO942853L (no) 1995-02-03
RO113557B1 (ro) 1998-08-28
US5618814A (en) 1997-04-08
CN1041091C (zh) 1998-12-09
HUT70957A (en) 1995-11-28
NO942853D0 (fr) 1994-08-01
RU94028278A (ru) 1996-08-27
CZ184594A3 (en) 1995-02-15

Similar Documents

Publication Publication Date Title
EP1324045A3 (fr) Bibliothèques chimiques factorielles
ZA965934B (en) Chemical compounds.
ZA966610B (en) Chemical compounds.
DK0839126T3 (da) Fremgangsmåde til fremstilling af organiske nitrogenforbindelser, specielle organiske nitrogenforbindelser og blandinger af sådanne forbindelser samt deres anvendelse som brændstof- og smøremiddeladditiver
AU5992694A (en) Modular humeral component system
EP0617286A3 (fr) Support biospécifique en phase solide.
AU7453596A (en) Locking differential
EP0660690A4 (fr) Adaptateur pour flacons.
EP0649411A4 (fr) Composes bores.
AU5450794A (en) Modular, multi-level groundwater sampler
NO984081D0 (no) Pyrimido£5,4-d|pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremtilling derav
NO301479B1 (no) Trisubstituerte pyrimido £5,4-d| pyrimidiner for modulering av multimedikamentresistens, legemidler som inneholder disse forbindelser og fremgangsmåter ved fremstilling av dem
AU4128093A (en) Locking slide block
ZA966427B (en) The preparation of fluorinated organic compounds.
AU3427193A (en) Pyrimidin compounds useful as herbicides
DK0633070T3 (da) Fremgangsmåde til pulvercoating til emner
FR2705394B1 (fr) Assemblage modulaire de coffres de dépot de sûreté.
EP0683676A4 (fr) Biodistribution dirigee des petites molecules.
EP0623992A3 (fr) Oscillateur.
IS4190A (is) Hliðstæð aðferð til framleiðslu á 1,5 bensódíasepín afleiðum
EP0612480A3 (fr) Enrobage ressemblant à de la pâte.
EP0677456A4 (fr) Receptacle a revetement.
AU6646994A (en) 1,5-benzodiazepines useful as gastrin or cck-antagonists
EP0629626A3 (fr) Composés spirophotochromiques substitués par le groupe cyclopropyl.
FR2705762B1 (fr) Sécurité de briquet.